Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Music-STAR trial: study protocol for a randomised controlled trial to assess the impact of live and recorded music-based interventions on preoperative stress, mood, pain and biomarkers in neurosurgical patients.

Created on 06 Oct 2026

Authors

Amara Anyanwu, Dima Suki, Annelise Huynh, Giulio Draetta, Kyle Noll, J Jack Lee, Frederick F Lang, Mei Rui

Published in

BMJ open. Volume 16. Issue 10. Pages e110925. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

Neurosurgical patients commonly experience significant preoperative anxiety, which can negatively impact surgical outcomes and recovery trajectories. Music, as a powerful neurophysiological modulator of the human stress response, offers a non-pharmacological, non-invasive and cost-effective approach to anxiolysis by stabilising the hypothalamic-pituitary-adrenal axis and autonomic nervous system. The goal of this study is to evaluate the effects of live and recorded music on preoperative stress, serum-level and plasma-level biomarkers, perceived pain, anxiety and mood states in neurosurgical cancer patients.
Enrolled neurosurgical patients (n=132) will be equally randomised to one of three groups: (1) simulated live music intervention using a Steinway Spirio M recording/player piano, (2) recorded music played through ambient speakers, or (3) control (no music). The musical selections will all incorporate 16 validated Compositional Elements of Relaxation (CERs). The intervention period will last 30 min.Endpoints will be assessed using validated pre-intervention and post-intervention questionnaires, including the State-Trait Anxiety Inventory-State subscale (STAI-S), the Profile of Mood States-Short Form (POMS-SF), and the Visual Analogue Scale for Pain (VASP), as well as serum biomarkers (eg, interleukin-6, cortisol and epinephrine) analysed using broad-spectrum proteomic and metabolomic approaches.The study will be conducted from January 2025 to January 2028.
This study protocol was approved by the review board at MD Anderson Cancer Center on 12 May 2025. The results of this study will be disseminated through peer-reviewed journals and presented at relevant scientific conferences.
NCT06536504.

PMID:
42833720
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement